Renalytix annual current ratio
2019
2020
2021
2022
2023
2024
2025
Renalytix Current Ratio Growth & History (RENX)
Renalytix's current ratio was 1.21 for fiscal 2025.
View full Renalytix company overviewRenalytix annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-06-30 | 1.21 | 0.68 | +127.03% |
| 2024 | 2024-06-30 | 0.53 | −1.13 | −68.05% |
| 2023 | 2023-06-30 | 1.67 | −2.13 | −56.16% |
| 2022 | 2022-06-30 | 3.80 | −5.66 | −59.82% |
| 2021 | 2021-06-30 | 9.46 | 4.95 | +109.75% |
| 2020 | 2020-06-30 | 4.51 | −3.69 | −45.01% |
| 2019 | 2019-06-30 | 8.20 | — | — |
Renalytix quarterly current ratio
Q4.20
Q4.21
Q3.22
Q4.22
Q1.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2025-12-31 | 1.57 | −0.86 | −35.22% |
| Q2 2025 | 2024-12-31 | 2.43 | 1.84 | +310.06% |
| Q1 2025 | 2024-09-30 | 0.24 | −0.85 | −77.92% |
| Q4 2024 | 2024-06-30 | 0.53 | −1.13 | −68.05% |
| Q3 2024 | 2024-03-31 | 0.42 | −2.01 | −82.61% |
| Q2 2024 | 2023-12-31 | 0.59 | — | — |
| Q1 2024 | 2023-09-30 | 1.09 | −1.50 | −57.95% |
| Q4 2023 | 2023-06-30 | 1.67 | −2.13 | −56.16% |
| Q3 2023 | 2023-03-31 | 2.43 | −0.05 | −1.87% |
| Q1 2023 | 2022-09-30 | 2.58 | — | — |
| Q4 2022 | 2022-06-30 | 3.80 | −5.66 | −59.82% |
| Q3 2022 | 2022-03-31 | 2.48 | — | — |
| Q4 2021 | 2021-06-30 | 9.46 | 4.95 | +109.75% |
| Q4 2020 | 2020-06-30 | 4.51 | — | — |
Renalytix current ratio trends
Over the last five fiscal years, Renalytix's current ratio decreased from 4.51 to 1.21, a change of −3.30. The latest reported quarter, Q2 2026, shows 1.57.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Renalytix source filings ↗